TipRanks
Atara Biotherapeutics (CH:ATRA)
:ATRA
Switzerland Market
ATRA
Atara Biotherapeutics
RESEARCH TOOLSreports

Atara Biotherapeutics (ATRA) Income Statement

0 Followers

Atara Biotherapeutics Income Statement

Last quarter (Q2 2026), Atara Biotherapeutics's total revenue was $630.00K, a decrease of -96.42% from the same quarter last year. In Q2, Atara Biotherapeutics's net income was $-4.83M. See Atara Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 120.77M$ 128.94M$ 8.57M$ 63.57M$ 20.34M
Gross Profit
$ 99.56M$ 107.93M$ -313.00K$ -206.42M$ -261.66M
Operating Expenses
$ 63.70M$ 191.37M$ 275.69M$ 74.10M$ 78.80M
Depreciation and Amortization
$ 2.12M$ 5.05M$ 4.83M$ 5.65M$ 9.35M
EBITDA
$ 38.63M$ -75.75M$ -266.00M$ -222.26M$ -330.75M
Operating Income
$ 35.86M$ -83.44M$ -276.01M$ -280.51M$ -340.46M
Other Income/Expenses
$ -3.14M$ -1.98M$ -105.00K$ 52.22M$ 367.00K
Pretax Income
$ 32.72M$ -85.42M$ -276.11M$ -228.29M$ -340.10M
Net Income
$ 32.69M$ -85.40M$ -276.13M$ -228.30M$ -340.14M
Per Share Metrics
Basic EPS
$ 2.61$ -11.41$ -65.18$ -55.96$ -90.78
Diluted EPS
$ 2.57$ -11.41$ -65.18$ -55.96$ -90.78
Weighted Average Shares Outstanding
 12.54M 7.49M 4.24M 4.08M 3.75M
Weighted Average Shares Outstanding (Diluted)
 12.72M 7.49M 4.24M 4.08M 3.75M
Currency in USD

Atara Biotherapeutics Earnings and Revenue History